<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glazmag</journal-id><journal-title-group><journal-title xml:lang="ru">The EYE ГЛАЗ</journal-title><trans-title-group xml:lang="en"><trans-title>The EYE GLAZ</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2222-4408</issn><issn pub-type="epub">2686-8083</issn><publisher><publisher-name>Академия медицинской оптики и оптометрии</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33791/2222-4408-2024-1-42-47</article-id><article-id custom-type="elpub" pub-id-type="custom">glazmag-523</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Роль полноты клинического обследования в безопасности ношения контактных линз для контроля миопии (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>The role of a complete clinical examination for the safety of wearing contact lenses for myopia control (literature review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маков</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Makov</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маков Илья Николаевич, врач-офтальмолог</p><p>620014, г. Екатеринбург, ул. Хохрякова, д. 63</p></bio><bio xml:lang="en"><p>Ilia N. Makov, Ophthalmologist</p><p>63, Hohryakova Str., Yekaterinburg, 620014</p></bio><email xlink:type="simple">inmakov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ООО «Центр коррекции зрения “Доктор Линза”»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>“Doctor Linza” vision center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>02</day><month>04</month><year>2024</year></pub-date><volume>26</volume><issue>1</issue><fpage>42</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Академия медицинской оптики и оптометрии, 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Академия медицинской оптики и оптометрии</copyright-holder><copyright-holder xml:lang="en">Академия медицинской оптики и оптометрии</copyright-holder><license xlink:href="https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.theeyeglaz.com/jour/article/view/523">https://www.theeyeglaz.com/jour/article/view/523</self-uri><abstract><p>Актуальность. В свете наследственно-физиологической теории патогенеза миопии Э. С. Аветисова и работ, посвященных влиянию периферического миопического и гиперметропического дефокуса на рефрактогенез, логично рассматривать миопию как мультифакториальное заболевание, а пациенты с миопией должны получать комплексное наблюдение и лечение у смежных специалистов. Однако, на практике общесоматический статус пациентов и наличие у них сопутствующих заболеваний зачастую не исследованы. Цель: проанализировать данные литературы, касающиеся влияния сопутствующей патологии пациентов на ношение ими контактных линз, оценить потенциальные факторы риска у таких пациентов и обратить внимание практикующего врача офтальмолога на значение полного клинического обследования. Материалы и методы. По теме исследования отобраны статьи на таких ресурсах как Pubmed, eLibrary, Medline за последние 30 лет. Были проанализированы 43 источника литературы, из которых 37 опубликованы за последние 10 лет. Результаты. Авторами данных работ описывается, как прием лекарственных препаратов из группы ретиноидов, наличие аллергического конъюнктивита, заболеваний щитовидной железы, ревматоидного артрита, сахарного диабета и особенности психоэмоционального состояния пациента могут оказывать влияние на частоту возникновения осложнений при использовании контактных линз. Заключение. С учетом многочисленных исследований, посвященных взаимосвязи прогрессирования миопии с общесоматическими заболеваниями, а также особенностей контактной коррекции при сопутствующих патологиях, можно говорить о высокой значимости полного клинического обследования каждого пациента.</p></abstract><trans-abstract xml:lang="en"><p>Introduction. In the light of E.S. Avetisov’s hereditary-physiological theory of the pathogenesis of myopia and works devoted to the infl uence of peripheral myopic and hyperopic defocus on refraction, it makes sense to consider myopia as a multifactorial disease, so patients with myopia should receive comprehensive monitoring and treatment from related specialists. However, in practice, the general somatic status of patients and the presence of concomitant diseases in them are often not studied. Purpose: to analyze literature data on the impact of patients’ comorbidities on their wearing of contact lenses, to assess potential risk factors in such patients, and to draw the attention of an ophthalmologist to the importance of a complete clinical examination. Materials and methods. An analysis was made of publications on such resources as Pubmed, eLibrary, Medline over the past 30 years. 43 literature sources were analyzed, of which 37 were published no later than 10 years. Results. The authors of these publications describe how taking drugs from the group of retinoids, the presence of allergic conjunctivitis, thyroid diseases, rheumatoid arthritis, diabetes mellitus, and the characteristics of the patient’s psycho-emotional state can infl uence the incidence of complications when using contact lenses. Conclusions. Taking into account numerous studies on the relationship between the progression of myopia and general somatic diseases, as well as the features of contact correction in childhood with comorbidities, we can say that a complete clinical examination of each patient is of high importance.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>контактные линзы</kwd><kwd>ортокератология (ОК)</kwd><kwd>ортокератологические линзы</kwd><kwd>сбор анамнеза</kwd><kwd>слезная пленка</kwd><kwd>синдром сухого глаза</kwd><kwd>ретиноиды</kwd></kwd-group><kwd-group xml:lang="en"><kwd>contact lenses</kwd><kwd>orthokeratology (OK)</kwd><kwd>orthokeratology lenses</kwd><kwd>patient history taking</kwd><kwd>tear fi lm</kwd><kwd>dry eye syndrome</kwd><kwd>retinoids</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральные клинические рекомендации по миопии. Общероссийская общественная организация «Ассоциация врачей-офтальмологов». http://avo-portal.ru/documents/fkr/ФКР_миопия_дети_взрослые_2022.pdf (Дата обращения: 23.03.2023 г.)</mixed-citation><mixed-citation xml:lang="en">Federal clinical guidelines for myopia. URL: http://avo-portal.ru/documents/fkr/FKR_myopia_children_adults_2022.pdf (In Russ.) (Accessed 23.03.2023).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Si JK, Tang K, Bi HS, Guo DD, Guo JG, Wang XR. Orthokeratology for myopia control: a meta-analysis. Optom Vis Sci. 2015;92(3):252–257. doi: 10.1097/OPX.0000000000000505</mixed-citation><mixed-citation xml:lang="en">Si JK, Tang K, Bi HS, Guo DD, Guo JG, Wang XR. Orthokeratology for myopia control: a meta-analysis. Optom Vis Sci. 2015;92(3):252–257. doi: 10.1097/OPX.0000000000000505</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sun Y, Xu F, Zhang T, Liu M, Wang D, Chen Y, Liu Q. Orthokeratology to control myopia progression: a meta-analysis. PLoS One. 20159;10(4):e0124535. doi: 10.1371/journal. pone.0124535</mixed-citation><mixed-citation xml:lang="en">Sun Y, Xu F, Zhang T, Liu M, Wang D, Chen Y, Liu Q. Orthokeratology to control myopia progression: a meta-analysis. PLoS One. 20159;10(4):e0124535. doi: 10.1371/journal. pone.0124535</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gifford KL, Richdale K, Kang P, Aller TA, Lam CS, Liu YM, et al. IMI – clinical management guidelines report. Invest Ophthalmol Vis Sci. 201928;60(3):M184–M203. doi: 10.1167/iovs.18-25977</mixed-citation><mixed-citation xml:lang="en">Gifford KL, Richdale K, Kang P, Aller TA, Lam CS, Liu YM, et al. IMI – clinical management guidelines report. Invest Ophthalmol Vis Sci. 201928;60(3):M184–M203. doi: 10.1167/iovs.18-25977</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sharmila F, Abinayapriya, Ramprabhu K, Kumaramanickavel G, Sudhir RR, Sripriya S. Genetic analysis of axial length genes in high grade myopia from Indian population. Meta Gene. 2014;2:164–175. doi: 10.1016/j.mgene.2014.01.004</mixed-citation><mixed-citation xml:lang="en">Sharmila F, Abinayapriya, Ramprabhu K, Kumaramanickavel G, Sudhir RR, Sripriya S. Genetic analysis of axial length genes in high grade myopia from Indian population. Meta Gene. 2014;2:164–175. doi: 10.1016/j.mgene.2014.01.004</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cai XB, Shen SR, Chen DF, Zhang Q, Jin ZB. An overview of myopia genetics. Exp Eye Res. 2019;188:107778. doi: 10.1016/j. exer.2019.107778</mixed-citation><mixed-citation xml:lang="en">Cai XB, Shen SR, Chen DF, Zhang Q, Jin ZB. An overview of myopia genetics. Exp Eye Res. 2019;188:107778. doi: 10.1016/j. exer.2019.107778</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tedja MS, Haarman AEG, Meester-Smoor MA, Kaprio J, Mackey DA, Guggenheim JA, et al; CREAM Consortium. IMI – myopia genetics report. Invest Ophthalmol Vis Sci. 2019;60(3):M89– M105. doi: 10.1167/iovs.18-25965</mixed-citation><mixed-citation xml:lang="en">Tedja MS, Haarman AEG, Meester-Smoor MA, Kaprio J, Mackey DA, Guggenheim JA, et al; CREAM Consortium. IMI – myopia genetics report. Invest Ophthalmol Vis Sci. 2019;60(3):M89– M105. doi: 10.1167/iovs.18-25965</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cao K, Wan Y, Yusufu M, Wang N. Signifi cance of outdoor time for myopia prevention: a systematic review and meta-analysis based on randomized controlled trials. Ophthalmic Res. 2020;63(2):97–105. doi: 10.1159/000501937. Epub 2019 Aug 20</mixed-citation><mixed-citation xml:lang="en">Cao K, Wan Y, Yusufu M, Wang N. Signifi cance of outdoor time for myopia prevention: a systematic review and meta-analysis based on randomized controlled trials. Ophthalmic Res. 2020;63(2):97–105. doi: 10.1159/000501937. Epub 2019 Aug 20</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Althnayan YI, Almotairi NM, Alharbi MM, Alamer HB, Alqahtani HB, Alfreihi S. Myopia progression among school-aged children in the COVID-19 distance-learning era. Clin Ophthalmol. 2023;17:283–290. doi: 10.2147/OPTH.S381061</mixed-citation><mixed-citation xml:lang="en">Althnayan YI, Almotairi NM, Alharbi MM, Alamer HB, Alqahtani HB, Alfreihi S. Myopia progression among school-aged children in the COVID-19 distance-learning era. Clin Ophthalmol. 2023;17:283–290. doi: 10.2147/OPTH.S381061</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bergler-Czop B, Bilewicz-Stebel M, Stańkowska A, Bilewicz-Wyrozumska T. Side effects of retinoid therapy on the quality of vision. Acta Pharm. 2016;66(4):471–478. doi: 10.1515/acph-2016-0039</mixed-citation><mixed-citation xml:lang="en">Bergler-Czop B, Bilewicz-Stebel M, Stańkowska A, Bilewicz-Wyrozumska T. Side effects of retinoid therapy on the quality of vision. Acta Pharm. 2016;66(4):471–478. doi: 10.1515/acph-2016-0039</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: A large, retrospective review. Dermatol Ther. 2017;30(4). doi: 10.1111/dth.12483</mixed-citation><mixed-citation xml:lang="en">Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: A large, retrospective review. Dermatol Ther. 2017;30(4). doi: 10.1111/dth.12483</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ozyol P, Ozyol E, Yildirim FE. Remodeling of cornea with isotretinoin treatment. Eye Contact Lens. 2021;47(6):366–371. doi: 10.1097/ICL.0000000000000769</mixed-citation><mixed-citation xml:lang="en">Ozyol P, Ozyol E, Yildirim FE. Remodeling of cornea with isotretinoin treatment. Eye Contact Lens. 2021;47(6):366–371. doi: 10.1097/ICL.0000000000000769</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol. 2001;132(3):299–305. doi: 10.1016/s00029394(01)01024-8</mixed-citation><mixed-citation xml:lang="en">Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol. 2001;132(3):299–305. doi: 10.1016/s00029394(01)01024-8</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ruiz-Lozano RE, Hernández-Camarena JC, Garza-Garza LA, Bustamante-Arias A, Colorado-Zavala MF, Cardenas-de la Garza JA. Isotretinoin and the eye: A review for the dermatologist. Dermatol Ther. 2020;33(6):e14029. doi: 10.1111/dth.14029</mixed-citation><mixed-citation xml:lang="en">Ruiz-Lozano RE, Hernández-Camarena JC, Garza-Garza LA, Bustamante-Arias A, Colorado-Zavala MF, Cardenas-de la Garza JA. Isotretinoin and the eye: A review for the dermatologist. Dermatol Ther. 2020;33(6):e14029. doi: 10.1111/dth.14029</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Barbosa AP, Oliveira FR, Rocha FJD, Muglia VF, Rocha EM. Lacrimal gland atrophy and dry eye related to isotretinoin, androgen, and prolactin: differential diagnosis for Sjögren’s syndrome. Arq Bras Oftalmol. 2021;84(1):78–82. doi: 10.5935/0004-2749.20210012</mixed-citation><mixed-citation xml:lang="en">Barbosa AP, Oliveira FR, Rocha FJD, Muglia VF, Rocha EM. Lacrimal gland atrophy and dry eye related to isotretinoin, androgen, and prolactin: differential diagnosis for Sjögren’s syndrome. Arq Bras Oftalmol. 2021;84(1):78–82. doi: 10.5935/0004-2749.20210012</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Melnik BC. Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity. Acta Derm Venereol. 2017;97(2):173–181. doi: 10.2340/00015555-2535 17. Ding J, Kam WR, Dieckow J, Sullivan DA. The infl uence of 13-cis retinoic acid on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2013;54(6):4341–4350. doi: 10.1167/iovs.13-11863</mixed-citation><mixed-citation xml:lang="en">Melnik BC. Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity. Acta Derm Venereol. 2017;97(2):173–181. doi: 10.2340/00015555-2535 17. Ding J, Kam WR, Dieckow J, Sullivan DA. The infl uence of 13-cis retinoic acid on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2013;54(6):4341–4350. doi: 10.1167/iovs.13-11863</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Alanazi SA, Alomran AA, Abusharha A, Fagehi R, Al-Johani NJ, El-Hiti GA, Masmali AM. An assessment of the ocular tear film in patients with thyroid disorders. Clin Ophthalmol. 2019;13:1019–1026. doi: 10.2147/OPTH.S210044</mixed-citation><mixed-citation xml:lang="en">Alanazi SA, Alomran AA, Abusharha A, Fagehi R, Al-Johani NJ, El-Hiti GA, Masmali AM. An assessment of the ocular tear film in patients with thyroid disorders. Clin Ophthalmol. 2019;13:1019–1026. doi: 10.2147/OPTH.S210044</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rocha EM, Mantelli F, Nominato LF, Bonini S. Hormones and dry eye syndrome: an update on what we do and don’t know. Curr Opin Ophthalmol. 2013;24(4):348–355. doi: 10.1097/ICU.0b013e32836227bf</mixed-citation><mixed-citation xml:lang="en">Rocha EM, Mantelli F, Nominato LF, Bonini S. Hormones and dry eye syndrome: an update on what we do and don’t know. Curr Opin Ophthalmol. 2013;24(4):348–355. doi: 10.1097/ICU.0b013e32836227bf</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Aboud S, Abd Elkhalek M, Aly N, Abd Elaleem E. Ocular involvement and its manifestations in rheumatoid arthritis patients. Delta Journal of Ophthalmology. 2017;18(2):57. doi: 10.4103/djo.djo_17_17</mixed-citation><mixed-citation xml:lang="en">Aboud S, Abd Elkhalek M, Aly N, Abd Elaleem E. Ocular involvement and its manifestations in rheumatoid arthritis patients. Delta Journal of Ophthalmology. 2017;18(2):57. doi: 10.4103/djo.djo_17_17</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ma W, Wang G, Li X, Wu H, Liu Z, Dong N, Li C. Study of factors influencing dry eye in rheumatoid arthritis. J Ophthalmol. 2020;2020:5768679. doi: 10.1155/2020/5768679</mixed-citation><mixed-citation xml:lang="en">Ma W, Wang G, Li X, Wu H, Liu Z, Dong N, Li C. Study of factors influencing dry eye in rheumatoid arthritis. J Ophthalmol. 2020;2020:5768679. doi: 10.1155/2020/5768679</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Artifoni M, Rothschild PR, Brézin A, Guillevin L, Puéchal X. Ocular inflammatory diseases associated with rheumatoid arthritis. Nat Rev Rheumatol. 2014;10(2):108–116. doi: 10.1038/ nrrheum.2013.185</mixed-citation><mixed-citation xml:lang="en">Artifoni M, Rothschild PR, Brézin A, Guillevin L, Puéchal X. Ocular inflammatory diseases associated with rheumatoid arthritis. Nat Rev Rheumatol. 2014;10(2):108–116. doi: 10.1038/ nrrheum.2013.185</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wirta DL, Torkildsen GL, Moreira HR, Lonsdale JD, Ciolino JB, Jentsch G, et al. A clinical phase II study to assess effi cacy, safety, and tolerability of waterfree cyclosporine formulation for treatment of dry eye disease. Ophthalmology. 2019;126(6):792–800. doi: 10.1016/j.ophtha.2019.01.024</mixed-citation><mixed-citation xml:lang="en">Wirta DL, Torkildsen GL, Moreira HR, Lonsdale JD, Ciolino JB, Jentsch G, et al. A clinical phase II study to assess effi cacy, safety, and tolerability of waterfree cyclosporine formulation for treatment of dry eye disease. Ophthalmology. 2019;126(6):792–800. doi: 10.1016/j.ophtha.2019.01.024</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">O’Donnell C, Efron N. Diabetes and contact lens wear. Clin Exp Optom. 2012;95(3):328–337. doi: 10.1111/j.14440938.2012.00738.x</mixed-citation><mixed-citation xml:lang="en">O’Donnell C, Efron N. Diabetes and contact lens wear. Clin Exp Optom. 2012;95(3):328–337. doi: 10.1111/j.14440938.2012.00738.x</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">O’Donnell C, Efron N, Boulton AJ. A prospective study of contact lens wear in diabetes mellitus. Ophthalmic Physiol Opt. 2001;21(2):127–138. doi: 10.1046/j.14751313.2001.00555.x</mixed-citation><mixed-citation xml:lang="en">O’Donnell C, Efron N, Boulton AJ. A prospective study of contact lens wear in diabetes mellitus. Ophthalmic Physiol Opt. 2001;21(2):127–138. doi: 10.1046/j.14751313.2001.00555.x</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Holland EJ, Mannis MJ, Lee WB. Ocular surface disease: cornea, conjunctiva and tear fi lm. London: Elsevier/Saunders; 2013.</mixed-citation><mixed-citation xml:lang="en">Holland EJ, Mannis MJ, Lee WB. Ocular surface disease: cornea, conjunctiva and tear fi lm. London: Elsevier/Saunders; 2013.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cai D, Zhu M, Petroll WM, Koppaka V, Robertson DM. The impact of type 1 diabetes mellitus on corneal epithelial nerve morphology and the corneal epithelium. Am J Pathol. 2014;184(10):2662–2670. doi: 10.1016/j.ajpath.2014.06.016</mixed-citation><mixed-citation xml:lang="en">Cai D, Zhu M, Petroll WM, Koppaka V, Robertson DM. The impact of type 1 diabetes mellitus on corneal epithelial nerve morphology and the corneal epithelium. Am J Pathol. 2014;184(10):2662–2670. doi: 10.1016/j.ajpath.2014.06.016</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Leong YY, Tong L. Barrier function in the ocular surface: from conventional paradigms to new opportunities. Ocul Surf. 2015;13(2):103–109. doi: 10.1016/j.jtos.2014.10.003</mixed-citation><mixed-citation xml:lang="en">Leong YY, Tong L. Barrier function in the ocular surface: from conventional paradigms to new opportunities. Ocul Surf. 2015;13(2):103–109. doi: 10.1016/j.jtos.2014.10.003</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Vieira-Potter VJ, Karamichos D, Lee DJ. Ocular complications of diabetes and therapeutic approaches. Biomed Res Int. 2016;2016:3801570. doi: 10.1155/2016/3801570</mixed-citation><mixed-citation xml:lang="en">Vieira-Potter VJ, Karamichos D, Lee DJ. Ocular complications of diabetes and therapeutic approaches. Biomed Res Int. 2016;2016:3801570. doi: 10.1155/2016/3801570</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Han SB, Yang HK, Hyon JY. Influence of diabetes mellitus on anterior segment of the eye. Clin Interv Aging. 2018;14:53–63. doi: 10.2147/CIA.S190713</mixed-citation><mixed-citation xml:lang="en">Han SB, Yang HK, Hyon JY. Influence of diabetes mellitus on anterior segment of the eye. Clin Interv Aging. 2018;14:53–63. doi: 10.2147/CIA.S190713</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Ding J, Liu Y, Sullivan DA. Effects of insulin and high glucose on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2015;56(13):7814–7820. doi: 10.1167/iovs.15-18049</mixed-citation><mixed-citation xml:lang="en">Ding J, Liu Y, Sullivan DA. Effects of insulin and high glucose on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2015;56(13):7814–7820. doi: 10.1167/iovs.15-18049</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Markoulli M, Flanagan J, Tummanapalli SS, Wu J, Willcox M. The impact of diabetes on corneal nerve morphology and ocular surface integrity. Ocul Surf. 2018;16(1):45–57. doi: 10.1016/j.jtos.2017.10.006</mixed-citation><mixed-citation xml:lang="en">Markoulli M, Flanagan J, Tummanapalli SS, Wu J, Willcox M. The impact of diabetes on corneal nerve morphology and ocular surface integrity. Ocul Surf. 2018;16(1):45–57. doi: 10.1016/j.jtos.2017.10.006</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Sen DK, Sarin GS. Tear glucose levels in normal people and in diabetic patients. Br J Ophthalmol. 1980;64(9):693–695. doi: 10.1136/bjo.64.9.693</mixed-citation><mixed-citation xml:lang="en">Sen DK, Sarin GS. Tear glucose levels in normal people and in diabetic patients. Br J Ophthalmol. 1980;64(9):693–695. doi: 10.1136/bjo.64.9.693</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Elsherif M, Moreddu R, Alam F, Salih AE, Ahmed I, Butt H. Wearable smart contact lenses for continual glucose monitoring: a review. Front Med (Lausanne). 2022 4;9:858784. doi: 10.3389/fmed.2022.858784</mixed-citation><mixed-citation xml:lang="en">Elsherif M, Moreddu R, Alam F, Salih AE, Ahmed I, Butt H. Wearable smart contact lenses for continual glucose monitoring: a review. Front Med (Lausanne). 2022 4;9:858784. doi: 10.3389/fmed.2022.858784</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Urgacz A, Mrukwa E, Gawlik R. Adverse events in allergy sufferers wearing contact lenses. Postepy Dermatol Alergol. 2015;32(3):204–209. doi: 10.5114/pdia.2015.48071</mixed-citation><mixed-citation xml:lang="en">Urgacz A, Mrukwa E, Gawlik R. Adverse events in allergy sufferers wearing contact lenses. Postepy Dermatol Alergol. 2015;32(3):204–209. doi: 10.5114/pdia.2015.48071</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kumar P, Elston R, Black D, Gilhotra S, DeGuzman N, Cambre K. Allergic rhinoconjunctivitis and contact lens intolerance. CLAO J. 1991;17(1):31–34.</mixed-citation><mixed-citation xml:lang="en">Kumar P, Elston R, Black D, Gilhotra S, DeGuzman N, Cambre K. Allergic rhinoconjunctivitis and contact lens intolerance. CLAO J. 1991;17(1):31–34.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">McMonnies CW. How contact lens comfort may be infl uenced by psychiatric and psychological conditions and mechanisms. Clin Exp Optom. 2014;97(4):308–310. doi: 10.1111/cxo.12122</mixed-citation><mixed-citation xml:lang="en">McMonnies CW. How contact lens comfort may be infl uenced by psychiatric and psychological conditions and mechanisms. Clin Exp Optom. 2014;97(4):308–310. doi: 10.1111/cxo.12122</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">McMonnies CW. Psychological and other mechanisms for endof-day soft lens symptoms. Optom Vis Sci. 2013;90(6):e175– 181. doi: 10.1097/OPX.0b013e318292624b</mixed-citation><mixed-citation xml:lang="en">McMonnies CW. Psychological and other mechanisms for endof-day soft lens symptoms. Optom Vis Sci. 2013;90(6):e175– 181. doi: 10.1097/OPX.0b013e318292624b</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Liu YM, Xie P. The safety of orthokeratology – a systema tic review. Eye Contact Lens. 2016;42(1):35–42. doi: 10.1097/ ICL.0000000000000219</mixed-citation><mixed-citation xml:lang="en">Liu YM, Xie P. The safety of orthokeratology – a systema tic review. Eye Contact Lens. 2016;42(1):35–42. doi: 10.1097/ ICL.0000000000000219</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Tao Z, Wang J, Zhu M, Lin Z, Zhao J, Tang Y, Deng H. Does orthokeratology wearing affect the tear quality of children? Front Pediatr. 2022;9:773484. doi: 10.3389/ fped.2021.773484</mixed-citation><mixed-citation xml:lang="en">Tao Z, Wang J, Zhu M, Lin Z, Zhao J, Tang Y, Deng H. Does orthokeratology wearing affect the tear quality of children? Front Pediatr. 2022;9:773484. doi: 10.3389/ fped.2021.773484</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Koh S. Contact lens wear and dry eye: beyond the known. Asia Pac J Ophthalmol (Phila). 2020;9(6):498–504. doi: 10.1097/ APO.0000000000000329</mixed-citation><mixed-citation xml:lang="en">Koh S. Contact lens wear and dry eye: beyond the known. Asia Pac J Ophthalmol (Phila). 2020;9(6):498–504. doi: 10.1097/ APO.0000000000000329</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Плотникова ЕВ. Применение флюоресцеина в клинической практике врача-офтальмолога. The EYE ГЛАЗ. 2019;21(4(128)):41–48. doi: 10.33791/2222-4408-2019-441-48 Plotnikova EV. The use of fluorescein in ophthalmic practice. The EYE GLAZ. 2019;21(4 (128)):41–48. (In Russ.) doi: 10.33791/2222-4408-2019-4-41-48</mixed-citation><mixed-citation xml:lang="en">Плотникова ЕВ. Применение флюоресцеина в клинической практике врача-офтальмолога. The EYE ГЛАЗ. 2019;21(4(128)):41–48. doi: 10.33791/2222-4408-2019-441-48 Plotnikova EV. The use of fluorescein in ophthalmic practice. The EYE GLAZ. 2019;21(4 (128)):41–48. (In Russ.) doi: 10.33791/2222-4408-2019-4-41-48</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi: 10.1016/j.jtos.2017.05.008</mixed-citation><mixed-citation xml:lang="en">Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi: 10.1016/j.jtos.2017.05.008</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
